Regulatory processes for rare disease drugs in the united states and european union: flexibilities and collaborative opportunities
Auteur :
National Academies of Sciences, Engineering, and Medicine / Health and Medicine Division / Board on Health Sciences Policy / Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union
Éditeur :
National Academies Press
ISBN :
9780309726559
Date de publication :
30 oct. 2024
Dimensions :
22,9 x 15,2 cm
Langue :
Anglais
Pays d'origine :
USA
Rare diseases, such as sickle cell disease and thalassemia, affect up to 30 million people in the United States and at least 300 million across the globe.